Abstract
This Report will analyze the biochemical nature of metabolomics, the technologies behind
metabolomics, metabonomics related approaches, and the appropriate market potentials. This Report
highlights new developments in chemical network (biochemical pathways) technology and the analytical
tools developed to facilitate drug discovery. The Report provides market trends and evaluates
metabolonomic pertaining to the pharmaceutical industry and the potential of being applied in the
areas of drug discovery and development, and preventive screening/diagnostics. In addition, this
Report indicates target compound analysis by discussing methods that measure the quantification of
specific metabolites. Profiles of the major players in the metabolomics/metabonomics and systems
biology field are also included.